539206
GVBL
Start SIP
Invest Now
Start SIP in GVBL
Performance
- Low
- ₹24
- High
- ₹27
- 52 Week Low
- ₹21
- 52 Week High
- ₹94
- Open Price₹25
- Previous Close₹25
- Volume4,641
Investment Returns
- Over 1 Month -17.91%
- Over 3 Month -29.87%
- Over 6 Month -48.21%
- Over 1 Year -68.54%
Smart Investing Starts Here Start SIP with Genomic Valley Biotech for Steady Growth!
Genomic Valley Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 76.9
- PEG Ratio
- -1.3
- Market Cap Cr
- 8
- P/B Ratio
- 2
- Average True Range
- 2.65
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.61
- RSI
- 46.59
- MFI
- 49.41
Genomic Valley Biotech Financials
Genomic Valley Biotech Technicals
EMA & SMA
Current Price
₹25.17
+
0.44
(1.78%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹24.87
- 50 Day
- ₹28.00
- 100 Day
- ₹33.23
- 200 Day
- ₹41.17
Resistance and Support
25.57
- R3 31.15
- R2 29.57
- R1 27.15
- S1 23.15
- S2 21.57
- S3 19.15
Genomic Valley Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-10-15 | Quarterly Results | |
| 2025-08-07 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results | |
| 2024-12-06 | Others | Inter alia - To consider and Approve (1) The Directors Report for the Year 2023-24. (2) 30th AGM of the Company and Other Business Matters. |
Genomic Valley Biotech F&O
About Genomic Valley Biotech
- NSE Symbol
- GVBL
- BSE Symbol
- 539206
- Managing Director
- Mr. Yogesh Agrawal
- ISIN
- INE574D01010
Similar Stocks to Genomic Valley Biotech
Genomic Valley Biotech FAQs
Genomic Valley Biotech share price is ₹25 As on 31 December, 2025 | 13:23
The Market Cap of Genomic Valley Biotech is ₹7.7 Cr As on 31 December, 2025 | 13:23
The P/E ratio of Genomic Valley Biotech is 76.9 As on 31 December, 2025 | 13:23
The PB ratio of Genomic Valley Biotech is 2 As on 31 December, 2025 | 13:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.